Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019158 (
hepatitis
)
30,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although
B and T lymphocyte attenuator
(
BTLA
) was originally identified as an inhibitory coreceptor selectively expressed on Th1 cells and B cells, recent studies have revealed that
BTLA
is expressed on a variety of cells, including macrophages, dendritic cells, and NK cells, and modulates their functions. However, the role of
BTLA
in the regulation of NKT cell function remains unknown. In this study, we found that
BTLA
was expressed on NKT cells at the levels similar to those on T cells and that
BTLA
-deficient (
BTLA
(-/-)) NKT cells produced larger amounts of IL-4 and IFN-gamma upon alpha-glactosylceramide stimulation as compared with wild-type (WT) NKT cells. In vivo,
BTLA
(-/-) mice produced larger amounts of IL-4 and IFN-gamma upon Con A injection and were more susceptible to Con A-induced
hepatitis
than WT mice. In addition, the augmentation of Con A-induced
hepatitis
in
BTLA
(-/-) mice was not observed in
BTLA
/NKT-double deficient mice. Moreover, NKT(-/-) mice reconstituted with
BTLA
(-/-) NKT cells were significantly more susceptible to Con A-induced
hepatitis
as compared with NKT (-/-) mice reconstituted with WT NKT cells. These results suggest that
BTLA
functions as the inhibitory coreceptor of NKT cells and plays a critical role in the prevention of NKT cell-mediated liver injury.
...
PMID:Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis. 1994 73
MRL/Mp-Fas (lpr) (MRL-lpr) mice develop a systemic autoimmune disease and are considered to be a good model for systemic lupus erythematosus in humans. We have recently shown that mice lacking
B and T lymphocyte attenuator
(
BTLA
), an inhibitory co-receptor expressed mainly on lymphocytes, on a 129SvEv background spontaneously develop lymphocytic infiltration in multiple organs and an autoimmune
hepatitis
(AIH)-like disease. In this study, we investigated the role of
BTLA
in the pathogenesis of autoimmune diseases in MRL-lpr mice. We found that
BTLA
-deficient (
BTLA
(-/-)) MRL-lpr/lpr mice developed severe lymphocytic infiltration in salivary glands, lungs, pancreas, kidneys and joints as compared with
BTLA
-sufficient (
BTLA
(+/+)) MRL-lpr/lpr mice. In addition, although AIH-like disease was not found in
BTLA
(+/+) MRL-lpr/lpr mice, AIH-like disease was exacerbated in
BTLA
(-/-) MRL-lpr/lpr mice as compared with that in
BTLA
(-/-) 129SvEv mice. These results suggest that
BTLA
plays a protective role in autoimmune diseases in MRL-lpr mice and that AIH-like disease develops in
BTLA
(-/-) mice even in the absence of Fas-dependent signaling.
...
PMID:Lack of B and T lymphocyte attenuator exacerbates autoimmune disorders and induces Fas-independent liver injury in MRL-lpr/lpr mice. 2152 81
The
BTLA
-HVEM checkpoint axis plays extensive roles in immunomodulation and diseases, including cancer and autoimmune disorders. However, the functions of this checkpoint axis in
hepatitis
remain limited. In this study, we explored the regulatory role of the Btla-Hvem axis in a ConA-induced
hepatitis
model in zebrafish. Results showed that Btla and Hvem were differentially expressed on intrahepatic Cd8
+
T cells and hepatocytes. Knockdown of Btla or Hvem significantly promoted hepatic inflammation. Btla was highly expressed in Cd8
+
T cells in healthy liver but was downregulated in inflamed liver, as evidenced by a disparate proportion of Cd8
+
Btla
+
and Cd8
+
Btla
-
T cells in individuals without or with ConA stimulation. Cd8
+
Btla
+
T cells showed minimal cytotoxicity to hepatocytes, whereas Cd8
+
Btla
-
T cells were strongly reactive. The depletion of Cd8
+
Btla
-
T cells reduced
hepatitis
, whereas their transfer enhanced hepatic inflammation. These observations indicate that Btla endowed Cd8
+
Btla
+
T cells with self-tolerance, thereby preventing them from attacking hepatocytes. Btla downregulation deprived this tolerization. Mechanistically, Btla-Hvem interaction contributed to Cd8
+
Btla
+
T cell tolerization, which was impaired by Hvem knockdown but rescued by soluble Hvem protein administration. Notably, Light was markedly upregulated on Cd8
+
Btla
-
T cells, accompanied by the transition of Cd8
+
Btla
+
Light
-
to Cd8
+
Btla
-
Light
+
T cells during
hepatitis
, which could be modulated by Cd4
+
T cells. Light blockade attenuated
hepatitis
, thereby suggesting the positive role of Light in hepatic inflammation. These findings provide insights into a previously unrecognized Btla-Hvem-Light regulatory network in hepatic homeostasis and inflammation, thus adding a new potential therapeutic intervention for
hepatitis
.
...
PMID:BTLA-HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish. 3156 9